BPC157 TB500 in the UK compared: bundle vs blend vs separate vials, price per mg from US vendor listings, UK legal status, WADA and the 2026 FDA vote.
Independently ranked by quality, purity and value.
BPC-157 10mg from Reviva X, lyophilized powder. Third-party COA published by the vendor. Research use only.
TB-500 10mg from Reviva X, lyophilized powder. Third-party COA published by the vendor. Research use only.
BPC-157 peptide for research, 10mg vial. Independent lab testing, lot COA published before purchase, US sto...
TB-500 10mg from Thrive Peptides, lyophilized powder. Third-party COA published by the vendor. Research use only.
TB-500 peptide for research, 10mg vial. Independent lab testing with the lot COA published before purchase....
Wolverine Stack peptide for sale: BPC-157 + TB-500 in one vial, independently lab tested, lot COA published...
GLOW Stack peptide for research: GHK-Cu 50mg, TB-4 10mg, BPC-157 10mg. Independent lab tested with the lot ...
BPC-157 10mg from Thrive Peptides, lyophilized powder. Third-party COA published by the vendor. Research use only.
Every pick has a batch-matched certificate of analysis we can read.
We check that real potency matches what the label promises.
Simple, transparent formulas — no mystery fillers or additives.
Scored on real cost per serving, not just sticker price.
Order online; most orders arrive in a few days in discreet packaging.
Every guide is reviewed by at least one member of this panel before publication.
Board-certified toxicologist with a focus on peptide metabolite profiling. Evaluates adverse-event reports and safety margins from preclinical data.
Tracks peptide vendor sourcing, cold-chain logistics and batch-matching practices to verify supply-chain integrity.
Endocrinologist and clinical researcher specializing in GLP-1 agonists, growth-hormone secretagogues and metabolic peptide therapies.
MD/PhD specializing in endocrine pharmacology. Reviews dosing literature, safety profiles and drug-interaction considerations.
On 23 July 2026 a US Food and Drug Administration advisory panel voted 8-6, with one abstention, to recommend both BPC-157 and TB-500 for the list of substances American compounding pharmacies may use. That vote put the BPC157 TB500 pairing back in the headlines, and UK readers have been asking us what it changes here. The short answer is very little: neither peptide is a licensed medicine in the UK, both are sold as research compounds, and both are banned in sport.
This website explains how the pair can be bought (as a two-vial kit or as a single vial or in separate vials), calculates the pricing per milligram based on the US listings of the suppliers, and summarizes the situation concerning safety and legislation in the UK in a simple way. It does not offer any advice on the doses given that there is no recognized human dose available.
The stack is simply two separate research peptides sold together. BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. TB-500 is a synthetic fragment related to thymosin beta-4, a protein the body makes naturally.
The majority of research associated with the two substances done so far has employed tissue repair models in animals. BPC-157 has been examined mostly in studies involving rodents with muscle, tendon and intestinal tissues, whereas TB-500 has been investigated mainly in research involving tissue repair animal models. Data involving either of the two substances in humans consists mostly of small uncontrolled studies.
The popular name for the pairing is the "Wolverine stack". It is a marketing label, not a medical term. Our page on BPC-157 vs TB-500 sets out how the two compounds differ in origin and in the research behind them.
BPC-157 and TB-500 are offered by dealers in three forms, and depending on the option you select, how much you pay and the freedom you persist with will also change.
There is also a three-peptide option, the GLOW Stack, which adds GHK-Cu to the pair. We compare it with the two-peptide bundle on a separate page, and the full bundle-versus-blend argument is on BPC-157 TB-500: bundle, blend or separate vials.
According to the information provided by the vendors in their price updates for the US region, the Real Peptides bundle is deemed as the most economical option for ascertaining the pricing of both these peptides in per mg terms.
| Product | Vendor | Listed price (USD) | Contents | Price per mg |
|---|---|---|---|---|
| Wolverine Peptide Stack | Real Peptides | $40.80 | 10 mg BPC-157 + 10 mg TB-500 | $2.04 |
| BPC-157 10mg | Real Peptides | $43.20 | 10 mg BPC-157 | $4.32 |
| TB-500 (Thymosin Beta-4) | Real Peptides | $48.00 | 10 mg TB-500 | $4.80 |
| GLOW Stack | Real Peptides | $86.40 | 50 mg GHK-Cu + 10 mg TB-500 + 10 mg BPC-157 | Mixed contents |
| BPC-157 + TB-500 Blend | Peptide God | $59.95 | Vial size not listed in our data | Check label |
| TB-500 | Peptide God | $35.00 | Vial size not listed in our data | Check label |
Purchasing Real Peptides' two individual vials apart would cost $91.20, which is $50.40 higher than the bundle that contains the same amount of ingredients.
The vendors are both located in the US and use US dollars for their pricing, but we haven't verified whether their products are delivered to the UK. Before you place the order, check with the vendor's website if they ship to the UK.
Your card issuer may charge exchange fees or international transaction charges. Packages entering the UK can come under the scrutiny of Border Force. It's also possible that imported goods will incur VAT and customs duty on arrival. The threshold for free shipping applies to US vendors ($100 at Peptide God and $250 at Real Peptides) along with Peptide God's 30 days free returns. It's important to check Real Peptides' returns policy since it is not mentioned in the data we have.
For the vendor comparison and the Trustpilot picture, see Wolverine stack peptides: vendors and price per mg.
BPC-157 and TB-500 are not licensed medicines in the UK, and neither is approved by the US FDA for human use. They are sold as research compounds. Under the Human Medicines Regulations 2012 a product is classed by its intended use, so anything promoted to treat injury, cognition or metabolic health can be treated as a medicine, with licensing requirements attached. In April 2026 The Guardian reported that the MHRA was investigating UK peptide clinics making medicinal claims about unregulated peptides, with BPC-157 named among the widely promoted compounds. A "research use only" label does not make a product legal to supply for human use, and it does not mean it was made to medicine standards. The same rules apply to every BPC157 TB500 product sold here.
Both compounds are on the World Anti-Doping Agency Prohibited List, and UK Anti-Doping applies that list to UK athletes. Anyone subject to testing should not use them, and our WADA and UKAD guide explains why a "research" label is no defence.
On safety, the honest position is that there is no controlled human trial data on the pair, so there is no reliable list of side effects. In September 2023 the FDA placed both peptides in Category 2 of its interim bulk-substances lists while it reviewed safety concerns. The July 2026 panel vote is non-binding: the FDA must still decide and then go through proposed and final rulemaking with public comment. As of that meeting, compounding with either peptide was not yet permitted in the US.
The fact that there was an 8-6 split vote shows that experts are divided. For health-related issues, consult your doctor or pharmacist.